← brief for 2026-11-03 · Slowing decline

UBT251 Injection Phase II Clinical Study (CKD)

Trial No results yet Not peer reviewed

Key takeaways

This is a new trial registration for a drug called UBT251. It is an injection being tested in people with chronic kidney disease who are also overweight or obese. The study is just starting, so there are no results yet.

Who did this work

Run by The United Bio-Technology (Hengqin) Co., Ltd..
Sites: Peking University First Hospital

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-11-03
https://clinicaltrials.gov/study/NCT07134335